Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that the company has nominated ...
Enter Generative AI: A Paradigm Shift Today, generative AI is changing this equation. Unlike traditional AI that analyzes existing data, generative AI can...
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a significant leadership transition with the appointment ...
Nxera Pharma Co., Ltd. announces that it has achieved a development milestone under its multi-target collaboration and license agreement with Eli Lilly a...
Medcrypt, the leading provider of proactive cybersecurity solutions for medical devices, announced today a major milestone in its continued growth, fuele...
Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powe...
Topline data expected by year end Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithi...
Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a U...
Liebherr USA, Co. refrigerators and freezers is excited to announce the addition of a new combination refrigerator-freezer to its scientific appliance li...
In this exclusive interview with BioPharma BoardRoom, Jessay Devassy, Manager, Bioprocess Applications at Ecolab Bioprocessing&...
Eli Lilly and Company announced that the Australian Therapeutic Goods Administration (TGA) has granted marketing authorization for Kisunla (d...
Synfini, Inc., the leader in AI-driven agile chemistry for better molecule discovery, announced today that it has entered a collaboration with biotechnol...
Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline ...
ODAC recommendation based on the positive progression-free survival and clinical benefit in the Phase 3 AQUILA study If approved, DARZALEX FASPRO® w...
© 2025 Biopharma Boardroom. All Rights Reserved.
